000			02357 a2200637 4500
005			20250516061030.0
264		0	_c20111207
008			201112s 0 0 eng d
022			_a1460-2105
024	7		_a10.1093/jnci/djr310 _2doi
040			_aNLM _beng _cNLM
100	1		_aYothers, Greg
245	0	0	_aOutcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cOct 2011
300			_a1498-506 p. _bdigital
500			_aPublication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aBlack or African American _xstatistics & numerical data
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aColonic Neoplasms _xdrug therapy
650	0	4	_aConfounding Factors, Epidemiologic
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHealth Status Disparities
650	0	4	_aHealthcare Disparities
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aLevamisole _xadministration & dosage
650	0	4	_aLomustine _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Staging
650	0	4	_aOdds Ratio
650	0	4	_aProportional Hazards Models
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
650	0	4	_aVincristine _xadministration & dosage
650	0	4	_aWhite People _xstatistics & numerical data
700	1		_aSargent, Daniel J
700	1		_aWolmark, Norman
700	1		_aGoldberg, Richard M
700	1		_aO'Connell, Michael J
700	1		_aBenedetti, Jacqueline K
700	1		_aSaltz, Leonard B
700	1		_aDignam, James J
700	1		_aBlackstock, A William
773	0		_tJournal of the National Cancer Institute _gvol. 103 _gno. 20 _gp. 1498-506
856	4	0	_uhttps://doi.org/10.1093/jnci/djr310 _zAvailable from publisher's website
999			_c21230028 _d21230028